纳米细胞眼滴:对最近进展的回顾
Valentina Paganini1, Patrizia Chetoni1,2, Mariacristina Di Gangi1
1Department of Pharmacy, University of Pisa, Pisa, Italy.
Expert opinion on drug delivery
|February 24, 2024
概括
纳米微粒通过改善溶解度和组织透来增强药物在眼睛中的输送,用于干眼,炎症和青光眼等疾病. 这种纳米技术为眼部药物生物可用性挑战提供了有希望的解决方案.
科学领域:
- 眼科纳米技术的应用
- 药物输送系统是药物输送系统.
- 生物医学工程 生物医学工程
背景情况:
- 纳米技术研究扩展到眼睛领域,纳米细胞作为一个关键的应用.
- 纳米颗粒提高了疏水药物的水溶性,并提高了它们通过眼组织的透率.
- 它们的小尺寸有助于通过眼部组织孔扩散,改善药物输送.
研究的目的:
- 审查最近关于眼科治疗中纳米细胞应用的文献.
- 为了解决由于眼睛生理学的眼睛药物生物可用性的限制.
- 专注于治疗领域:干眼,炎症和绿眼.
主要方法:
- 关于纳米细胞 (表面活性剂和两性聚合物) 的重要和最新文献的审查.
- 对抗水药物的纳米细胞封装的分析.
- 评估纳米微粒通过眼组织的透和透.
主要成果:
- 纳米细胞在克服眼部药物输送挑战方面显示出显著的潜力.
- 研究表明,针对干眼,炎症和玻璃眼的药物的生物可用性得到改善.
- 纳米粒有效地封装不溶性药物,增强其治疗功效.
结论:
- 纳米微粒是改善眼部药物生物可用性的有希望的解决方案.
- 预计纳米细胞自我组装分子的进一步开发将符合监管标准.
- 这种纳米技术有可能成为未来的眼科配方和治疗方法.
相关概念视频
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:22Microbiome of the Eye
The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...